Mar 2018

UNIFIED ACCESS SYSTEM FOR MEDICAL CANNABIS NEEDED

Blue Mountains GP Dr Teresa Towpik has spoken out to encourage others to review the research supporting the therapeutic use of cannabis taking into account “observational evidence” from patients and carers.

Dr Towpik was unsuccessful in her attempts to prescribe a medicinal cannabis product for a patient with chronic pain and cautioned that patients trying to access medicinal cannabis may resort to the black and miss out on proper medical management.

State-based rules make it increasingly difficult to access medicinal cannabis with GPs including RACGP President Dr Bastian Seidel calling for a unified system of access.

Read the article here.

 

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

READ MORE >

We have successfully passed three consecutive TGO93 and TGO100 tests on our medicinal cannabis products since our first commercial harvest at the end of 2019.

READ MORE >

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >